4.8 based on 26reviewsView this provider's reviews
Patient satisfaction ratings and reviews are based on personal opinions. Before you choose any doctor you should take into account their background, training, specialized experience AND their patient satisfaction to ensure they are the right fit for you.
Michele Pietro Sartori, M.D., joined the Texas Heart Institute in the Section of Cardiology at St Luke's Episcopal Hospital in 1989, and practices Diagnostic and Interventional Cardiology. He is a Clinical Associate Professor of Medicine at Baylor College of Medicine and on the teaching faculty of the Interventional Fellowship Program at the Texas Heart Institute. A native of Northern Italy, Dr. Sartori graduated Summa Cum Laude from Parma University Medical School in 1978 . He entered an internship and residency in Cardiovascular Disease at Parma University Affiliated Hospitals. After obtaining board certification in Cardiovascular Disease in Italy in 1981, he joined the University of Texas at Austin as an adjunct professor with the Department of Biochemistry to conduct research on the cardiovascular effects of Coenzyme Q10 under the mentorship of Karl Faulker, Welch Professor of Biochemistry who identified the Coenzyme Q10 molecule. Dr. Sartori arrived at Baylor College of Medicine in 1982 to continue his research with a grant from George R. Brown and the Brown Foundation. He completed a fellowship in Cardiovascular Disease and a residency in Internal Medicine at Baylor College of Medicine in Houston between 1983 and 1989. During his fellowship training, he received the Individual National Service Research award from the National Institutes of Health and grants from the American Heart Association, Texas Chapter, for the application of laser to the treatment of cardiovascular disease. Dr. Sartori is board certified in Internal Medicine, Cardiovascular Disease, Interventional Cardiology, Nuclear Cardiology, Cardiovascular Computed Tomography, Echocardiography, and by the International Board of Heart Rhythm Examiners and Device Implantation. He is a member of the Texas Heart Institute Society, the Texas Medical Association, and the American College of Cardiology. He is routinely invited to give presentations on new techniques and novel pharmacological treatments for heart disease in the United States and abroad. Dr. Sartori's interests are in non-invasive diagnosis of atherosclerosis and coronary artery disease and interventional treatment of peripheral and coronary artery disease. He has developed expertise in emergency treatment of myocardial infarction with coronary artery angioplasty and stenting. He has been one of the first interventional cardiologists in the Southwest of the US to adopt the use of percutaneous temporary ventricular assist devices to perform high-risk coronary angioplasty with orbital atherectomy in patients who are not good candidates for open-heart surgery because of diffuse and calcified disease. Since the introduction of new techniques for the percutaneous implantation of Aortic valves, Dr. Sartori has developed expertise with different prosthesis such as the Medtronic and Edward Sapient valves maximizing the benefit of a given valve design to the patient anatomy.